KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Other financing activities (2020 - 2025)

Historic Other financing activities for Repligen (RGEN) over the last 6 years, with Q3 2025 value amounting to $824000.0.

  • Repligen's Other financing activities rose 4280.76% to $824000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 1916.62%. This contributed to the annual value of $9.9 million for FY2024, which is 2528.16% down from last year.
  • According to the latest figures from Q3 2025, Repligen's Other financing activities is $824000.0, which was up 4280.76% from $676000.0 recorded in Q2 2025.
  • In the past 5 years, Repligen's Other financing activities ranged from a high of $12.3 million in Q1 2022 and a low of $352000.0 during Q2 2021
  • Its 5-year average for Other financing activities is $2.8 million, with a median of $1.2 million in 2024.
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 232342.52% in 2022, then crashed by 5527.79% in 2023.
  • Repligen's Other financing activities (Quarter) stood at $1.9 million in 2021, then crashed by 37.02% to $1.2 million in 2022, then dropped by 11.77% to $1.0 million in 2023, then tumbled by 54.34% to $479000.0 in 2024, then soared by 72.03% to $824000.0 in 2025.
  • Its Other financing activities stands at $824000.0 for Q3 2025, versus $676000.0 for Q2 2025 and $6.5 million for Q1 2025.